Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

ClinicalTrials.gov ID: NCT01927757

Public ClinicalTrials.gov record NCT01927757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm Trial to Evaluate the Efficacy of Etanercept in Moderate to Severe Rheumatoid Arthritis Patients Who Failed to Respond or Lost a Satisfactory Response to Treatment With Adalimumab When Used as Their First Biologic Agent

Study identification

NCT ID
NCT01927757
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

  • Etanercept Biological
  • Methotrexate Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2013
Primary completion
Jun 10, 2015
Completion
Jun 10, 2015
Last update posted
Jan 29, 2018

2013 – 2015

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Research Site Tuscaloosa Alabama 35406
Research Site Scottsdale Arizona 85258
Research Site Covina California 91723
Research Site Hemet California 92543
Research Site Murrieta California 92563
Research Site San Diego California 92108
Research Site Victorville California 92395
Research Site Denver Colorado 80230
Research Site Brandon Florida 33511
Research Site Dunedin Florida 34698
Research Site Largo Florida 33774
Research Site Palm Harbor Florida 34684
Research Site Tampa Florida 33609
Research Site Lawrenceville Georgia 30046
Research Site Bowling Green Kentucky 42101
Research Site Paducah Kentucky 42003
Research Site Fall River Massachusetts 02720
Research Site Battle Creek Michigan 49017
Research Site Lincoln Nebraska 68516
Research Site Smithtown New York 11787
Research Site Charlotte North Carolina 28210
Research Site Middleburg Heights Ohio 44130
Research Site Duncansville Pennsylvania 16635
Research Site Hixson Tennessee 37343
Research Site Austin Texas 78731
Research Site Corpus Christi Texas 78404
Research Site Houston Texas 77034
Research Site Victoria Texas 77901
Research Site Chesapeake Virginia 23320
Research Site Roanoke Virginia 24016
Research Site Seattle Washington 98133
Research Site Clarksburg West Virginia 26301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01927757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01927757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →